Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA DR. REDDYS LAB ASTRAZENECA PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 89.8 20.1 445.9% View Chart
P/BV x 16.2 3.8 426.6% View Chart
Dividend Yield % 0.3 0.7 43.9%  

Financials

 ASTRAZENECA PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
DR. REDDYS LAB
Mar-22
ASTRAZENECA PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4,5805,614 81.6%   
Low Rs2,5293,655 69.2%   
Sales per share (Unadj.) Rs322.21,294.6 24.9%  
Earnings per share (Unadj.) Rs24.6126.9 19.4%  
Cash flow per share (Unadj.) Rs31.4196.9 16.0%  
Dividends per share (Unadj.) Rs10.0030.00 33.3%  
Avg Dividend yield %0.30.6 43.5%  
Book value per share (Unadj.) Rs203.81,145.8 17.8%  
Shares outstanding (eoy) m25.00166.43 15.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.03.6 308.1%   
Avg P/E ratio x144.336.5 395.1%  
P/CF ratio (eoy) x113.123.5 480.7%  
Price / Book Value ratio x17.44.0 431.3%  
Dividend payout %40.623.6 171.7%   
Avg Mkt Cap Rs m88,863771,272 11.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,30238,858 5.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,056215,452 3.7%  
Other income Rs m1484,847 3.0%   
Total revenues Rs m8,204220,299 3.7%   
Gross profit Rs m86237,674 2.3%  
Depreciation Rs m17011,652 1.5%   
Interest Rs m10958 1.0%   
Profit before tax Rs m83029,911 2.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2148,789 2.4%   
Profit after tax Rs m61621,122 2.9%  
Gross profit margin %10.717.5 61.2%  
Effective tax rate %25.829.4 87.9%   
Net profit margin %7.69.8 78.0%  
BALANCE SHEET DATA
Current assets Rs m7,653177,880 4.3%   
Current liabilities Rs m3,92397,658 4.0%   
Net working cap to sales %46.337.2 124.4%  
Current ratio x2.01.8 107.1%  
Inventory Days Days6156 110.0%  
Debtors Days Days39113 34.4%  
Net fixed assets Rs m2,120106,819 2.0%   
Share capital Rs m50832 6.0%   
"Free" reserves Rs m5,044189,859 2.7%   
Net worth Rs m5,094190,691 2.7%   
Long term debt Rs m05,746 0.0%   
Total assets Rs m9,773284,699 3.4%  
Interest coverage x88.432.2 274.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 108.9%   
Return on assets %6.47.8 82.5%  
Return on equity %12.111.1 109.2%  
Return on capital %16.515.7 104.9%  
Exports to sales %047.1 0.0%   
Imports to sales %31.718.8 168.9%   
Exports (fob) Rs mNA101,544 0.0%   
Imports (cif) Rs m2,55240,401 6.3%   
Fx inflow Rs m442101,544 0.4%   
Fx outflow Rs m2,55240,401 6.3%   
Net fx Rs m-2,11061,143 -3.5%   
CASH FLOW
From Operations Rs m1,00828,108 3.6%  
From Investments Rs m47-26,387 -0.2%  
From Financial Activity Rs m-95-2,422 3.9%  
Net Cashflow Rs m96132 3,002.5%  

Share Holding

Indian Promoters % 0.0 26.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 4.0 50.7 8.0%  
FIIs % 2.6 27.3 9.6%  
ADR/GDR % 0.0 10.5 -  
Free float % 25.0 62.8 39.8%  
Shareholders   45,619 246,788 18.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    CIPLA    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Dr. Reddys Share Price Performance

Period ASTRAZENECA PHARMA Dr. Reddys S&P BSE HEALTHCARE
1-Day -1.75% -0.28% -0.93%
1-Month -1.38% 2.84% -4.27%
1-Year 16.70% -0.36% -10.68%
3-Year CAGR 8.21% 11.52% 17.23%
5-Year CAGR 23.68% 15.61% 9.48%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

Dr. Reddys paid Rs 30.0, and its dividend payout ratio stood at 23.6%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms 910 Points | Titan & Adani Ports Rally 6% | 5 Reasons Why Indian Markets are Rising Sensex Today Zooms 910 Points | Titan & Adani Ports Rally 6% | 5 Reasons Why Indian Markets are Rising(Closing)

After opening the day higher, Indian share markets continued their momentum throughout the day and ended on a firm footing.